Use of antihistamines in pediatrics

Journal of Investigational Allergology and Clinical Immunology

Volumn 17, Issue SUPPL.2, 2007, Pages 28-40

  Del Cuvillo, Alfonso ^a   Sastre, J ^b   Montoro, J ^c   Jauregui I ^d   Ferrer, M ^e   Davila I ^f   Bartra, J ^g   Mullol, J ^g   Valero, A ^g  

^a Clinica Dr Lobaton   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c HOSPITAL DE LA PLANA   (Spain)

^d HOSPITAL DE BASURTO   (Spain)

^e UNIVERSITY CLINIC OF NAVARRA   (Spain)

^f HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

Author keywords

Allergic conjunctivitis; Allergic rhinitis; Antihistamines; Atopic dermatitis; Children; Pediatrics

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZELASTINE; BROMPHENIRAMINE; CETIRIZINE; CHLORPHENIRAMINE; DESLORATADINE; DIPHENHYDRAMINE; EBASTINE; FEXOFENADINE; HYDROXYZINE; KETOTIFEN; LEVOCETIRIZINE; LORATADINE; TERFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

AGGRESSION; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANAPHYLAXIS; ANTICHOLINERGIC SYNDROME; ANTIINFLAMMATORY ACTIVITY; APPETITE; ASTHMA; ATOPIC DERMATITIS; BRAIN TOXICITY; CARDIOTOXICITY; COGNITIVE DEFECT; CONSCIOUSNESS DISORDER; COUGHING; DROWSINESS; DRUG ACTIVITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DRUG USE; HEART PALPITATION; HUMAN; MUSCLE SPASM; OTITIS MEDIA; QUALITY OF LIFE; RASH; RESPIRATORY DISTRESS; RESPIRATORY TRACT INFECTION; REVIEW; SEIZURE; SIDE EFFECT; SYNCOPE; WEIGHT GAIN; ANIMAL; CHILD; IMMUNOLOGY; INFLAMMATION; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; RESPIRATORY TRACT ALLERGY; TREATMENT OUTCOME;

ANIMALS; CHILD; CHILD, PRESCHOOL; HISTAMINE H1 ANTAGONISTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; INFLAMMATION; OTITIS MEDIA; QUALITY OF LIFE; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME;

EID: 38949204518     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Garde Garde J Ma, Ibáñez Sandín Ma D. Alergia en Menores de 14 años. In: Alergológica 2005. Factores epidemiológicos, clínicos y socioeconómicos de las enfermedades alérgicas en España en 2005. Madrid. Luzan 5, S.A. de Ediciones. 2006:325-387.
2. Simons FE. H1 antihistamines in children. Clin Allergy Immunol. 2002;17:437-464.
3. Simons FER, Roberts JR, Gu X, Kapur S, Simons KJ. The clinical pharmacology of brompheniramine in children. J Allergy Clin Immunol. 1999; 103:223-226.
4. Simons FER, Luciuk GH, Simons KJ. Pharmacokinetics and efficacy of chlorpheniramine in children. J Allergy Clin Immunol. 1982;69:376-381.
5. Simons KJ, Watson WTA, Martin TJ, Chen XY, Simons FER. Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults and children. J Clin Pharmacol. 1990;30:665-671.
6. Simons FER, Simons KJ, Becker AB, Haydey RP. Pharmacokinetics and antipruritic effects of hidroxyzine in children with atopic dermatitis. J Pediatr. 1984;104:123-127.
7. Schmidt-Redeman B, Brenneisen P, Schmidt-Redeman W, Gonda S. The determination of pharmacokinetic parameters of ketotifen in steady state in young children. Int J Clin Pharmacol Ther Toxicol. 1986;24:496-498.
8. Watson WTA, Simons KJ, Chen XY, Simons FER. Cetirizine: a pharmacokinetic and pharmacodynamic evaluation in children with seasonal allergic rhinitis. J Allergy Clin Immunol. 1989;84:457-464.
9. Desager JP, Dab I, Horsmans Y, Harvengt C. A pharmacokinetic evaluation of the second generation H1-receptor antagonist cetirizine in very young children. Clin Pharmacol Ther. 1993;53:431-435.
10. Spicak V, Dab I, Hulthoven R, Desager J-P, Klanova M, De Longueville M, Harvengt C. Pharmacokinetics and pharmocodynamics of cetirizine in infants an toddlers. Clin Pharmacol Ther. 1997;61:325-330.
11. Pitsiu M, Hussein Z, Majid O, Aaron L, de Longueville M, Stockis A. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years. Br J Clin Pharmacol. 2004;57:402-411.
12. Simons FE, Johnston L, Simons KJ. Clinical pharmacology of the H1-receptor antagonist cetirizine and loratadine in children. Pediatr Allergy Immunol. 2000; 11:116-119.
13. Simons FER, Watson WTA, Simons KJ. Pharmacokinetics and pharmacodynamics of ebastine in children. J Pediatr. 1993;122:641-646.
14. Simons FER, Bergman JN, Watson WTA, Simons KJ. The clinical pharmacology of fexofenadine in children. J Allergy Clin Immunol. 1996; 98:1062-1064.
15. Krishna R, Krishnawami S, Kitner B, Sankoh AJ, Jensen BK. The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride. Biopharm Drug Dispos. 2004; 25:373-387.
16. Lin CC, Radwanski E, Affrime MB, Cayen MN. Pharmacokinetics of loratadine in pediatric subjects. Am J Ther. 1995;2:504-508.
17. Salmun LM, HerronJM, Banfield C, Padhi D, Lorber R, Affrime MB. The pharmacokinetics, electrocardiographic effects and tolerability of loratadine syrup in children aged 2 to 5 years. Clin Ther. 2000;22:613-621.
18. Simons FE, the ETAC study group. Population pharmacokinetics of levocetirizine in very young childrIn: the pediatricians' perspective. Pediatr Allergy Immunol. 2005;16:97-103.
19. Hussein Z, Ptisius M, Majid O, Aarons L, de Longueville M, Stockis A, ETAC Study group. Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC study. Br J Clin Pharmacol. 2005; 59:28-37.
20. Cranwick N, Turkizova J, Fuchs M, Hulhoven R. Levocetirizine in 1-2 year old childrIn: pharmacokinetic and pharmacodynamic profile. Int J Clin Pharmacol Ther. 2005;43:172-177.
21. Simons FE, Simons KJ. Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years. J Allergy Clin Immunol. 116: 355-361.
22. Gupta SK, Kantesaria B, Banfield C, Wang Z. Desloratadine dose selection in children aged 6 months to 2 year: comparison of population pharmacokinetics between children and adults. Br J Clin Pharmacol. 2007; Epub ahead of print.
23. Okonkwo CA, Coker HAB, Agomo PU, Ogunbanwo JA, Mafe AG, Agomo CO Afolabi BM. Effect of chlorpheniramine on the pharmacokinetics of and response to chloroquine of Nigerian children with falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1999;93: 306-311.
24. Meltzer EO. Allergic rhinitis: managing the pediatric spectrum. Allergy Asthma Proc. 2006;27:2-8.
25. Juniper EF, Howland WC, Roberts NB, Thompson AK, King DR. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol. 1998;101:163-170.
26. Lack G. Pediatric allergic rhinitis and comorbid disorders. J Allergic Clin Immunol. 2001;108(1 suppl): S9-15.
27. Lai DS, Lue KH, Hsieh JC, Lin KL, Lee HS. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen and a placebo for the treatment of childhood perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2002;89: 589-598.
28. De Blic J, WahnU, Billard E, Alt R, Pujazon MC. Levocetirizine in childrIn: evidenced efficacy and safety in a 6 week randomized seasonal allergic trial. Pediatr Allergy Immunol. 2005;16: 267-75.
29. Potter PC, Paediatric levocetirizine study group. Efficacy and safety of levocetirizine on symptoms and health-related quality of life in children with perennial allergic rhinitis: a double-blind, placebo controlled randomized clinical trial. Ann Allergy Asthma Immunol. 2005;95:175-180.
30. Yang YH, Lin YT, Lu MY, Tsai MJ, Chiang BL. A double-blind, placebo controlled and randomized study of loratadine (clarityne) syrup for the treatment of allergic rhinitis in children aged 3 to 12 years. Asian Pac J Allergy Immunol. 2001;19:171-175.
31. Meltzer EO, Scheimann P, Rosado Pinto JE, Bachert C, Hedlin G, Wahn U, Finn AF Jr., Ruuth E. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis. A pooled analysis of three studies. Pediatr Allergy Immunol. 2004;15:253-260.
32. Serra HA, Alves O, Rizzo LF, Devoto FM, Ascierto H. Loratadine- pseudoephedrine in children with allergic rhinitis, a controlled double-blind trial. Br J Clin Pharmacol. 1998;45:147-150.
33. Baki A, Orhan F. The effect of loratadine in exercise induced asthma. Arch Dis Chile. 2002;86:38-39.
34. Ciprandi G, Tosca M, Ricca V, Passalacqua G, Fregonese L, Fasce L, Canónica GW. Cetirizine treatment of allergic cough in children with pollen allergy. Allergy. 1997;52:752-754.
35. Kabra SK, Pandey RM, Singh R, Seth V. Ketotifen for asthma in children aged 5 to 15 years: a randomized placebo controlled trial. Ann Allergy Asthma Immunol. 2000; 85 (1): 46-52.
36. Schwarzer G, Bassler D, Mitra A, Ducharme FM, Foster J. Ketotifen alone or as additional medication for long term control of asthma and wheeze in children. Cochrane Database Syst Rev. 2004; CD001384.
37. Corren J, Harris AG, Aaronson D, Beaucher W, Berkowitz R, Bronsky E, Chen R, Chervinsky P, Cohen R, Fourre J, Grossman J, Meltzer E, Pedinoff A, Stricker W, Wanderer A. Efficacy and safety of loratadina plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol. 1997;100:781-788.
38. Corren J, Manning BE, Thompson SF, Hennesy S, Strom BL. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol. 2004;113:415-419.
39. Corren J. The connection between allergic rhinitis and bronchial asthma. Curr Opin Pulm Med. 2007;13:13-18.
40. Iikura Y, Naspitz CK, Mikawa H, Talaricoficho S, Baba M, Sole D, Nishima S. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy. 1992;68:233-236.
41. Bustos GJ, Bustos D, Bustos GJ, Romero O. Prevention of asthma with ketotifen in preasthmatic childrIn: a three year follow-up study. Clin Exp Allergy. 1995;25:568-573.
42. Warner JO: ETAC study group. Early treatment of the atopic child. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow up. J Allergy Clin Immunol. 2001;108:929-937.
43. Grimfeld A, Holgates ST, Canonica GW, Bonini S, Borres MP, Adam D, Canseco Gonzalez C, Lobaton P, Patel P, Szczeklik A, Danzig MR, Roman I, Bismut H, Czarlewski W. Prophylactic management of children at risk for recurrent upper respiratory infection: the preventia I study. Clin Exp Allergy. 2004;34:1665-1672.
44. Hayashi K, Yanagi M, Wood-Baker R, Takamatsu I, Anami K. Oxatomide for stable asthma in adults and children. Cochrane Database Syst Rev. 2003; (2): CD002179.
45. Klein PA, Clark RA. An evidence-base review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol. 1999;135:1522-1525.
46. Munday J, Bloomfield R, Goldman M, Robey H, Kitowska GJ, Gwiezdziski Z, Wankiewicz, Marks R Protas-Drozd F, Mikaszewska M. Chlorfeniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component. Dermatology. 2002;205:40-45.
47. Diepgen TL; Early treatment of the atopic child study group. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-comtrolled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol. 2002;13:278-286.
48. Mortureux P, Léauté-Labrèze C, Legrain-Lifermann V, Lamireau T, Sarlangue J, Taieb A. Acute urticaria en infancy and early childhood. Arch Dermatol. 1998;134:319-323.
49. Simons FER, on behalf of the ETAC Study group. Prevention of acute urticaria en young children with atopic dermatitis. J Allergy Clin Immunol. 2001;107:703-706.
50. Fan HW, Marcopito LF, Cardoso JL, Franca FO, Malaque CM, Ferrari RA, Theakson RD, Warrell DA. Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for bothrops snake bites. BMJ. 1999;318:1451-1452.
51. Ditto AM, Krasnick J, Greenberger PA, Kelly KJ, McGrath K, Patterson R. Pediatric idiopathic anaphylaxis: experience with 22 patients. J Allergy Clin Immunol. 1997;100:320-326.
52. Sutter AI, Lemiengre M, Campbell H, Mackinnon HF. Antihistamines for the common cold. Cochrane Database Syst Rev. 2003;3:CD001267.
53. Teele DW, Klein JO, Rosner B. Middle ear disease and the practice of pediatrics: Burden during the first years of life. JAMA. 1983;249:1026-9.
54. Chonmaitree T, Patel JA, Left-Brown MA, Uchida T, Garofalo R, Owen MJ, Howie VM. Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media. J Infect Dis. 1994;169:1265-1270.
55. Griffin GH, Flynn C, Bailey RE, Schultz JK. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2006;4:CD003423.
56. Flynn CA, Griffin GH, Schultz JK. Decongestants and antihistamines for acute otitis media in children. Cochrane Database Syst Rev. 2004;3:CD001727.
57. Chang AB, Peake J, McElrea MS. Antihistamines for prolonged non-specific cough in children. Cochrane Database Syst Rev. 2006;3:CD005604.
58. Schroeder K, Fahey T. Over the counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev. 2004;4:CD001831.
59. Abelson MB, Ferzola NJ, McWhirter CL, Crampton HJ. Efficacy and safety of single and multiple dose ketotifen fumarate 0.025 ophtalmic solution in a pediatric population. Pediatr Allergy Immunol. 2004;6:551-557.
60. Secchi A, Ciprandi G, Leonardi A, Deschenes J, Abelson MB. Safety and efficacy comparison of emedastine 0.05% ophthalmic solution compared to levocabastine 0.05% ophthalmic suspension in pediatric subjects with allergic conjunctivitis. Emadine Study Group. Acta Ophtalmol Acand Suppl. 2000;230:42-47.
61. Ciprandi G, Catrullo A, Tosca M, Cerqueti P, Mondino C, Passalacqua G, Canónica GW. Azelastine eye drops reduce conjunctival hyperresponsiveness to hyperosmolar glucose challenge in children with asymptomatic mite conjunctivitis. J Investig Allergol Clin Immunol. 1999; 9 1:35-38.
62. Sabbah A, Marzetto M. Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children. Curr Med Res Opin. 1998;14: 161-170.
63. Vermeulen J, Mercer M. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children. Pediatr Allergy Immunol. 1994;5:209-213.
64. Karppinnen A, Kautianen H, Reunala T, Petman L, Reunala T, Brummer-Korvenkontio H. Loratadine in the treatment of mosquito-bite-sensitive children. Allergy. 2000;55:668-671.
65. English W, Bauer C-P. Dimethindene maleato in the treatment of pruritus caused by varicella zopster virus infection in children. Arzneim-Forsch/Drug Res. 1997;47:1233-1235.
66. Jones NL, Roifman CM, Grifiths AM, Sherman P. Ketotifeno therapy for acute ulcerative colitis in children. A pilot study. Digestive Diseases and Sciences. 1998;43:609-615.
67. Aroni K, Aivaliotis M, Liossi A, Davaris P. Eosinophilic cellulitis in a child successfully treated with cetirizine. Acta Derm Venereol. (Stockh) 1999;79: 332.
68. Ragg P, Davidson A. Comparison of the efficacy of paracetamol versus paracetamol, codeine and promethazine (painstop) for premedication and analgesia for myringotomy in children. Anaesth Intens Care. 1997;25:29-32.
69. Downs AT, Dembo J, Ferrerri G, Lyons TD, Pelphery A. A compartive study of midazolam to meperidine/promethazine as an IM sedative technique for the pediatric dental patient. J Dent Child. 1997;64:197-200.
70. Cengiz M, Baysal Z, Ganidagli S. Oral sedation with midazolam an diphenydramine compared with midazolam alone in children undergoing resonance imaging. Paediatr Anaesth. 2006;16:621-626.
71. Köseoglu V, Kürekci AE, Sorici U, Atay AA, Ozcan O. Comparison of the efficacy and side-effects of ondansertron and metoclopramide- diphenhydramine administered to control nausea and vomiting in children treated with antineoplasic chemotherapy: a prospective randomized study. Eur J Pediatr. 1998;157:806-810.
72. Sowunmi A, Oduola AMJ, Ogundahunsi OAT, Falade CO, Gbotosho GO, Salako LA. Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children. Trans R Soc Tropical Med Hyg. 1997;91:63-67.
73. Leurs R, Church MK, Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy. 2002;32:489-498.
74. Kalayci O, Saraclar Y, Adalioglu G, Sekerel B, Tuncer A. The effect of cetirizine on sulfidoleukotriene production by blood leukocytes in children with allergic rhinitis. Allergy. 1995;50:964-969.
75. Lanz MJ, Liu AH, Buchmeier AD, Nelson HS. Nasal nitric oxide decreases in children with grass pollen allergy with oral cetirizine syrup. J Allergy Clin Immunol. 1998;101:S244.
76. Fasce L, Ciprandi G, Pronzato C, Cozzani S, Tosca MA, Grimaldi J, Canonica GW. Cetirizine reduces ICAM-1 on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. Int Arch Allergy Immunol. 1996;109:272-276.
77. Uguz A, Sanlioglu S, Yuzbey S, Coskun M, Yegin O. The effect of cetirizine on IFN-gamma and IL-10 production in children with allergic rhinitis. Turk J Pediatr. 2005;47:111-115.
78. Ciprandi G, Tosca MA, Milanese M, Ricca V. Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis. Allerg Immunol (Paris). 2004;36:237-240.
79. Hung CH, Li Cy, Lai YS, Hsu PC, Hua YM, Yang KD. Discrepant clinical responses and blood chemokine profiles between two non-steroidal anti-inflammatory medications for children with mild persistent asthma. Pediatr Allergy Immunol. 2005;16:306-309.
80. Dizdar EA, Sekerel BE, Keskin O, Kalayci O, Adalioglu G, Dogan C, Tuncer A. The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2007;71:843-849.
81. Simons FE, Fraser TG, Reggin JD, Roberts JR, Simons KJ. Adverse central nervous system effects of older antihistamines in children. Pediatr Allergy Immunol. 1996;7:22-27.
82. Simons FE, Reggin JD, Roberts JR, Simons KJ. Benefits/risk ratio of the antihistamines (H1-receptor antagonist) terfenadine and chlorpheniramine in children. J Pediatr. 1994;124:979-983.
83. Ng KH, Chong D, Wong CK, Ong HT, Lee CY, Lee BW, Shek LP. Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo controlled comparative study. Pediatrics. 2004;113:116-121.
84. Lavenstein AF, Dacaney EP, Lasagna L, Vanmetre TE. Effect of cyproheptadine on asthmatic children. Study of appetite, weight gain and linear growth. JAMA. 1962;180:912-916.
85. Homnick DN, Marks JH, Hare KL, Bonnema SK. Long term trial of cyproheptadine as an appetite stimulant in cystic fibrosis. Pediatr Pulmonol. 2005;40:251-256.
86. Yasuhara A, Ochi A, Harada Y, Kobayashi Y. Infantile spasms associated with a histamine H1-antagonist. Neuropediatrics. 1998;29:320-321.
87. Yokohama H, Iinuma K, Yanai K, Watanabe, Sakurai E, Onodera K. Proconvulsant effect of ketotifeno, a histamine H1-antagonist, confirmed by the use of d-chlorfeniramine with monitoring electroencephalography. Meth Find Exp Clin Pharmacol. 1993;15:183-188.
88. Strayhorn JM Jr. Case study: Cyproheptadine and agresión in a five-year-old boy. J Am Acad Child Adolesc Psychiatr. 1998;37:668-670.
89. Lindsay CA, Williams GD, Levin DL. Fatal adult respiratory distress síndrome after diphenydramine toxicity in a child: A case report. Crit Care Med. 1995;23:771-781.
90. Cohen HA, Barzilai A, Matalon A, Harel L, Gross S. Fixed drug eruption of the penis due to hydroxycine hydrochloride. Ann Pharmacother. 1997;31:327-329.
91. Watemberg NA, Roth KS, Alehan FK, Epstein CE. Central anticholinergic syndrome on therapeutic doses of cyproheptadine. Pediatrics. 1999;103:158-160.
92. Garza MB, Osterhoudt KC, Rutstein R. Central anticholinergic 0syndrome from orphendarine in a 3-year-old. Ped Emerg Care. 02000;16:97-98.
93. 0Reilly JF Jr, Weisse ME. Topically induced diphenydramine 0toxicity. J Emerg Med. 1990;8:59-61.
94. 0Goetz CM, Lopez G, Dean BS, Krenzelok EP. Accidental 0childhood death from diphenhydramine overdosage. Am J 0Emerg Med. 1990;8:321-322.
95. 0Jumbelick MI, Hanzlick R, Cohle S. Alkylamine antihistamina 0toxicity and review of pediatric toxicology registry of the 0nacional Association of Medical Examiners. Am J Forensic Med 0Pathol. 1997;18:65-69.
96. 0Simons FE, Silas P, Portnoy JM, Catuogno J, Chapman D, 0Olufade AO, Pahrmd. Safety of cetirizine in infants 6 to 11 0months of age: randomized double-blind, placebo-comtrolled 0study. J Allergy Clin Immunol. 2003;111:1244-1248.
97. 0Bloom M, Staudinger H, Herron J. Safety of desloratadine 0syrup in children. Curr Med Res Opin. 2004;20:1959-1965.
98. 0Rossi GA, Tosca MA, Passalacqua G, Bianchi B, Le Garzie C, 0Canonica GW. Evidence of desloratadine syrup efficacy and 0tolerability in children with pollen-induced allergic rhinitis. 0Allergy. 2005;60:416-417.
99. 0Ostrom N, Welch M, Morris R, Rosen J, Wanderer A, Dockhorn 0R, Tinkelman D, Vandewalker M, Ziering W. Evaluation of 0ebastina, a new non-sedating antihistamine, in children 0with seasonal allergic rhinitis. J Allergy Clin Immunol. 01994;93:163.
100. 0Vuurman EFPM, van Veggel LMA, Uiterwijk MMC, Leutner D, 0O'Hanlon JF. Seasonal allergic rhinitis and antihistamine effects 0on children's learning. Ann Allergy. 1993;71:121-126.
101. 0Stevenson J, Cornah D, Evrard P, Vanderheyden V, Billard C, 0Bax M, Van Hout A, ETAC Study Group. Long-term evaluation 0of the impact of the H1-receptor antagonist cetirizine on 0the behavioural, cognitive, and psychomotor development 0of very young children with atopic dermatitis. Pediatr Res. 02002;52:251-257.
102. 0Wiley II JF, Gelber ML, Henretig FM, Wiley CC, Sandhu S, 0Loiselle j. Cardiotoxic effects of astemizol overdose in children. 0J Pediatr. 1992;120:799-802.
103. 0Delgado LF, Pferferman A, Solé D, Naspitz CK. Evaluation of 0the potential cardiotoxicity of the antihistamines terfenadine, 0astemizol, loratadina and cetirizine in atopic children. Ann 0Allergy Asthma Immunol. 1998;80:333-337.
104. 0Graft DF, Bernstein DL, Goldsobel A, Meltzer EO, Portnoy J, 0Long J. Safety of fexofenadine in children treated for seasonal 0allergic rhinitis. Ann Allergy Asthma Immunol. 2001;87:22-026.
105. 0Moss AJ, Chaikin P, Garcia JD, Guillen M, Roberts DJ, 0Morganroth J. A review of the cardiac systemic side-effects 0of antihistamines: ebastine. Clin Exp Allergy 1999;29 suppl. 03:200-205.
106. 0Shekelle PG, Wool SH, Eccles M, Grimshaw J. Clinical 0guidelines: developing guidelines. BMJ. 1999;318:593-596.